Cutting edge: Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome

Journal of Immunology

Volumn 181, Issue 6, 2008, Pages 3755-3759

  Kool, Mirjam ^a   Pétrilli, Virginie ^b   De Smedt, Thibaut ^c   Rolaz, Aline ^c   Hammad, Hamida ^a,d   Van Nimwegen, Menno ^a   Bergen, Ingrid M ^a   Castillo, Rosa ^b   Lambrecht, Bart N ^a,d   Tschopp, Júrg ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c BioAlliance Pharma   (France)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALUM ADJUVANT; ALUMINUM MAGNESIUM HYDROXIDE; ANTIGEN; CRYOPYRIN; IMJECT ALUM; IMMUNOLOGICAL ADJUVANT; INFLAMMASOME; INTERLEUKIN 1BETA; MULTIPROTEIN COMPLEX; OVALBUMIN; UNCLASSIFIED DRUG; ALUMINUM HYDROXIDE; ALUMINUM POTASSIUM SULFATE; AUTACOID; CARRIER PROTEIN; CIAS1 PROTEIN, MOUSE; IMMUNOLOGIC FACTOR; MAGNESIUM HYDROXIDE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL INFILTRATION; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; IMMUNOSTIMULATION; IN VIVO STUDY; INFLAMMATORY CELL; INNATE IMMUNITY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PERITONEUM MACROPHAGE; PHYSIOLOGY;

ADJUVANTS, IMMUNOLOGIC; ALUM COMPOUNDS; ALUMINUM HYDROXIDE; ANIMALS; CARRIER PROTEINS; DENDRITIC CELLS; FEMALE; IMMUNOLOGIC FACTORS; INFLAMMATION MEDIATORS; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MAGNESIUM HYDROXIDE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 56149119563     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.6.3755     Document Type: Article

References (28)

1. Parkinson, T. 2008. The future of Toll-like receptor therapeutics. Curr. Opin. Mol. Ther. 10: 21-31.
2. Daubenberger, C. A. 2007. TLR9 agonists as adjuvants for prophylactic and therapeutic vaccines. Curr. Opin. Mol. Ther. 9: 45-52. (Pubitemid 46438448)
3. Akira, S., and K. Takeda. 2004. Toll-like receptor signalling. Nat. Rev. Immunol. 4: 499-511.
4. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2: 947-950. (Pubitemid 32976167)
5. Gavin, A. L., K. Hoebe, B. Duong, T. Ota, C. Martin, B. Beutler, and D. Nemazee. 2006. Adjuvant-enhanced antibody responses in the absence of Toll-like receptor signaling. Science 314: 1936-1938.
6. Martinon, F., and J. Tschopp. 2007. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 14: 10-22. (Pubitemid 44911890)
7. Franchi, L., J. H. Park, M. H. Shaw, N. Marina-Garcia, G. Chen, Y. G. Kim, and G. Nunez. 2008. Intracellular NOD-like receptors in innate immunity, infection and disease. Cell. Microbiol. 10: 1-8. (Pubitemid 350239051)
8. Ting, J., and B. Davis. 2005. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol. 23: 387-414. (Pubitemid 40563175)
9. Agostini, L., F. Martinon, K. Burns, E. M. McDermott, P. N. Hawkins, and J. Tschopp. 2004. NALP3 forms an IL-1β processing inflammasome with increased activity in Muckle-Wells auto-inflammatory disorder. Immunity 20: 319-325. (Pubitemid 38388233)
10. Fritz, J. H., R. L. Ferrero, D. J. Philpott, and S. E. Girardin. 2006. Nod-like proteins in immunity, inflammation and disease. Nat. Immunol. 7: 1250-1257.
11. Petrilli, V., C. Dostert, D. A. Muruve, and J. Tschopp. 2007. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol. 19: 615-622. (Pubitemid 350236810)
12. Martinon, F., V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241. (Pubitemid 43372104)
13. Dostert, C., V. Petrilli, R. Van Bruggen, C. Steele, B. T. Mossman, and J. Tschopp. 2008. Induction of innate immune responses through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677. (Pubitemid 351928351)
14. Kool, M., T. Soullie, M. van Nimwegen, M. A. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205: 869-882. (Pubitemid 351549884)
15. Mariathasan, S., K. Newton, D. M. Monack, D. Vucic, D. M. French, W. P. Lee, M. Roose-Girma, S. Erickson, and M. V. Dixit. 2004. Differential activation of the inflammasome by caspase-1adaptors ASC and Ipaf. Nature 430: 213-218. (Pubitemid 38902430)
16. Eisenbarth, S. C., O. R. Colegio, W. O'Connor, F. S. Sutterwala, and R. A. Flavell. 2008. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature 453: 1122-1126.
17. Petrilli, V., S. Papin, C. Dostert, A. Mayor, F. Martinon, and J. Tschopp. 2007. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14: 1583-1589. (Pubitemid 47278844)
18. + for caspase-1 activation induced by intracellular and extracellular bacteria. J. Biol. Chem. 282: 18810-18818.
19. Mariathasan, S., D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, and V. M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232. (Pubitemid 43372102)
20. Idzko, M., H. Hammad, M. van Nimwegen, M. Kool, M. A. Willart, F. Muskens, H. C. Hoogsteden, W. Luttmann, D. Ferrari, F. Di Virgilio, et al. 2007. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat. Med. 13: 913-919. (Pubitemid 47222044)
21. Lindblad, E. B. 2004. Aluminium adjuvants-in retrospect and prospect. Vaccine 22: 3658-3668.
22. Glenny, A. T., C. G. Pope, H. Waddington, and U. Wallace. 1926. Immunological notes XVII to XXIV. J. Pathol. 29: 31-40.
23. Sun, H., K. G. Pollock, and J. M. Brewer. 2003. Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro. Vaccine 21: 849-855. (Pubitemid 36131100)
24. Li, H., S. Nookala, and F. Re. 2007. Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1β and IL-18 release. J. Immunol. 178: 5271-5276.
25. + T cell differentiation by aluminum-containing adjuvants. Vaccine 25: 4575-4585.
26. Li, H., S. B. Willingham, J. P. Ting, and F. Re. 2008. Cutting Edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181: 17-21.
27. Antonopoulos, C., M. Cumberbatch, R. J. Dearman, R. J. Daniel, I. Kimber, and R. W. Groves. 2001. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice. J. Immunol. 166: 3672-3677. (Pubitemid 32224888)
28. Shi, Y., J. E. Evans, and K. L. Rock. 2003. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 425: 516-521. (Pubitemid 37237047)